-
Phosbind Biotin LC: PVDF Workflow Guide
2026-08-16
Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes without relying on a sequence-matched phospho-specific antibody. It is suited to Western Blot phosphorylated protein detection with streptavidin-HRP and chemiluminescence, but not to aqueous-only workflows or long-term storage of working solutions.
-
ω-Agatoxin IVA TFA: Cav2.1 Workflow Guide
2026-08-15
ω-Agatoxin IVA TFA enables selective Cav2.1 inhibition for neuronal calcium current recording, synaptic transmission research, and epilepsy studies. Its nanomolar P/Q-channel activity and splice-sensitive pharmacology help distinguish P-type from Q-type responses while minimizing L- and T-type channel interference.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-08-14
AZD8055 is a selective, ATP-competitive mTOR inhibitor for controlled studies of mTORC1 signaling, mTORC2 signaling, cancer cell proliferation, and metabolism. It is useful for mechanistic preclinical experiments but is not appropriate for water-based formulations or studies whose primary goal is clinical efficacy prediction.
-
iPSC Organoids Reveal Pan-Genotype HEV Tropism
2026-08-14
This 2025 Gut study establishes induced pluripotent stem cell-derived liver, intestinal and brain organoids that support the complete life cycle of clinical hepatitis E virus genotypes 1, 3 and 4. The models resolve tissue-specific viral tropism, injury responses and partial ribavirin sensitivity, creating a human-relevant platform for HEV pathogenesis and antiviral research.
-
SB 431542: From ALK5 Biology to Translation
2026-08-13
A translational framework for using SB 431542 to interrogate TGF-β biology across fibrosis, oncology, stem cell, and immune research while preserving mechanistic discipline.
-
Anp32e Drives Renal Interstitial Fibrosis via TGF-β
2026-08-13
This study identifies Anp32e as an active promoter of renal interstitial fibrosis rather than merely a fibrosis-associated marker. Using patient tissue, a unilateral ureteral obstruction model, and proximal tubular cells, the authors connect Anp32e to TGF-β1/Smad3 activation and show that pathway inhibition can reverse Anp32e-associated fibrotic protein deposition.
-
RepSox and iPSC Platelet Assay Design
2026-08-12
RepSox is a potent ALK5 inhibitor for dissecting TGF-β signaling during stem-cell experiments. This evidence-aware guide distinguishes validated iPSC platelet findings from testable RepSox hypotheses and provides practical assay-design parameters.
-
PreScission Protease for Condensate-Ready Proteins
2026-08-12
PreScission Protease enables precise HRV 3C protease cleavage for producing tag-free proteins without overlooking construct-dependent condensate behavior. This article connects fusion-tag removal with experimental design for Drosophila Keap1, nuclear foci, and intrinsically disordered regions.
-
Morin: From Podocyte Energy to Translation
2026-08-11
Morin is more than a natural flavonoid antioxidant: emerging evidence positions it as a mechanistically informative tool for studying purine nucleotide cycling, mitochondrial energy metabolism, and podocyte injury. This article translates recent AMPD2-centered findings into practical experimental guidance, clarifies the compound’s preclinical maturity, and outlines how its enzyme-modulating and fluorescent properties can support integrated translational workflows.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-08-11
Cy5 NHS ester(Et) is a water-soluble reagent for covalently attaching fluorescent Cy5 groups to primary amines in proteins, peptides, and related biomolecules. It is suited to immediate-use protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy workflows, but not to ethanol-based protocols or long-term storage of prepared solutions.
-
MEG3, TGF-β, and NiO NP Pulmonary Fibrosis
2026-08-10
The reference study identifies a mechanistic relationship between reduced lncRNA MEG3, elevated TGF-β1, PI3K/AKT activation, and collagen deposition after nickel oxide nanoparticle exposure. Its combination of rat pulmonary injury modeling, A549-cell experiments, pharmacological inhibition, and MEG3 overexpression supports MEG3 as a regulatory brake on nanoparticle-associated fibrotic signaling.
-
Busulfan: Mechanism, Models, and Limits
2026-08-09
Busulfan is a DNA alkylating agent used to model DNA damage, cellular senescence, and germ-cell depletion. Evidence from WI38 fibroblasts and mouse ovaries supports distinct, model-specific outcomes and does not support postnatal neo-oogenesis after busulfan-induced ovarian injury.
-
SB-505124 hydrochloride: Applied Workflows
2026-08-08
SB-505124 hydrochloride provides reversible control of ALK4, ALK5, and ALK7 signaling for fibrosis, fibroblast activation, and TGF-β-driven remodeling assays. This guide connects pathway inhibition with practical phosphorylation, gene-expression, viability, gel-release, and mechanobiology workflows while highlighting controls and troubleshooting decisions.
-
SB 202190: Translational Leverage in p38 Biology
2026-08-07
SB 202190 (FHPI) is more than a selective p38 MAP kinase inhibitor: it is a mechanistic probe for connecting inflammatory signaling, apoptosis, and disease-relevant phenotypes. This thought-leadership guide shows translational researchers how to position the compound alongside colorectal cancer evidence, organoid workflows, and carefully bounded neurobiology studies.
-
7ACC2: Transforming Cancer Metabolism and Immunometabolic Re
2026-08-07
This thought-leadership article explores the mechanistic and translational frontiers opened by 7ACC2, a dual-action monocarboxylate transporter 1 inhibitor, in the context of cancer metabolism and immunometabolic reprogramming. Bridging recent advances from the 25-hydroxycholesterol–AMPK–STAT6 axis to actionable experimental protocols, it provides strategic guidance for translational researchers aiming to redefine the tumor microenvironment and enhance anti-tumor efficacy.